Dr. Karin Fox, MD

NPI: 1891999454
Total Payments
$5,024
2024 Payments
$114.65
Companies
9
Transactions
16

Payment Breakdown by Category

Travel$3,729 (74.2%)
Research$715.18 (14.2%)
Food & Beverage$440.13 (8.8%)
Education$139.80 (2.8%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $3,729 3 74.2%
Unspecified $715.18 5 14.2%
Food and Beverage $440.13 7 8.8%
Education $139.80 1 2.8%

Payments by Type

General
$4,309
11 transactions
Research
$715.18
5 transactions

Top Paying Companies

Company Total Records Latest Year
B. Braun Medical UK Ltd. $3,846 4 $0 (2019)
AMAG Pharmaceuticals, Inc. $715.18 5 $0 (2019)
Abbott Laboratories $139.80 1 $0 (2017)
BIOTRONIK INC. $139.78 1 $0 (2018)
Medtronic, Inc. $80.00 1 $0 (2024)
Lazarus 3D $42.00 1 $0 (2022)
Ethicon US, LLC $34.65 1 $0 (2024)
ACELL, INC. $14.85 1 $0 (2018)
Teleflex LLC $11.85 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $114.65 2 Medtronic, Inc. ($80.00)
2022 $42.00 1 Lazarus 3D ($42.00)
2021 $11.85 1 Teleflex LLC ($11.85)
2019 $4,561 9 B. Braun Medical UK Ltd. ($3,846)
2018 $154.63 2 BIOTRONIK INC. ($139.78)
2017 $139.80 1 Abbott Laboratories ($139.80)

All Payment Transactions

16 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/30/2024 Medtronic, Inc. V-LOC 180 (Device) Food and Beverage In-kind items and services $80.00 General
Category: Wound Closure
10/08/2024 Ethicon US, LLC EVARREST (Biological), VISTASEAL, SURGIFLO Hemostatic Matrix Food and Beverage In-kind items and services $34.65 General
Category: Biosurgical
09/20/2022 Lazarus 3D Food and Beverage Cash or cash equivalent $42.00 General
11/16/2021 Teleflex LLC QuikClot Control+ (Device) Food and Beverage In-kind items and services $11.85 General
Category: Vascular
09/12/2019 B. Braun Medical UK Ltd. Travel and Lodging Cash or cash equivalent $2,741.76 General
09/12/2019 B. Braun Medical UK Ltd. Travel and Lodging Cash or cash equivalent $870.06 General
09/12/2019 B. Braun Medical UK Ltd. Travel and Lodging Cash or cash equivalent $117.24 General
09/12/2019 B. Braun Medical UK Ltd. Food and Beverage Cash or cash equivalent $117.00 General
05/02/2019 AMAG Pharmaceuticals, Inc. In-kind items and services $280.90 Research
Study: A Phase 2b3a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of AMAG-423, a Digoxin Immune Fab, in Antepartum Subjects With Severe Preeclampsia
05/02/2019 AMAG Pharmaceuticals, Inc. In-kind items and services $201.95 Research
Study: A Phase 2b3a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of AMAG-423, a Digoxin Immune Fab, in Antepartum Subjects With Severe Preeclampsia
05/02/2019 AMAG Pharmaceuticals, Inc. In-kind items and services $82.32 Research
Study: A Phase 2b3a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of AMAG-423, a Digoxin Immune Fab, in Antepartum Subjects With Severe Preeclampsia
05/02/2019 AMAG Pharmaceuticals, Inc. In-kind items and services $77.00 Research
Study: A Phase 2b3a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of AMAG-423, a Digoxin Immune Fab, in Antepartum Subjects With Severe Preeclampsia
05/02/2019 AMAG Pharmaceuticals, Inc. In-kind items and services $73.01 Research
Study: A Phase 2b3a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of AMAG-423, a Digoxin Immune Fab, in Antepartum Subjects With Severe Preeclampsia
08/30/2018 BIOTRONIK INC. Food and Beverage In-kind items and services $139.78 General
02/21/2018 ACELL, INC. Food and Beverage Cash or cash equivalent $14.85 General
10/24/2017 Abbott Laboratories FreeStyle Lite system (Device), FreeStyle Lite system, FreeStyle Lite system Education Cash or cash equivalent $139.80 General
Category: Diabetes Care

Research Studies & Clinical Trials

Study Name Company Amount Records
A Phase 2b3a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of AMAG-423, a Digoxin Immune Fab, in Antepartum Subjects With Severe Preeclampsia AMAG Pharmaceuticals, Inc. $715.18 5

About Dr. Karin Fox, MD

Dr. Karin Fox, MD is a Obstetrics & Gynecology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1891999454.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karin Fox, MD has received a total of $5,024 in payments from pharmaceutical and medical device companies, with $114.65 received in 2024. These payments were reported across 16 transactions from 9 companies. The most common payment nature is "Travel and Lodging" ($3,729).

Practice Information

  • Specialty Obstetrics & Gynecology
  • Other Specialties Maternal & Fetal Medicine
  • Location Houston, TX
  • Active Since 06/14/2007
  • Last Updated 06/26/2012
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • NPI Number 1891999454

Products in Payments

  • FreeStyle Lite system (Device) $139.80
  • V-LOC 180 (Device) $80.00
  • EVARREST (Biological) $34.65
  • QuikClot Control+ (Device) $11.85

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics & Gynecology Doctors in Houston